Cd161-clec2d
(pdf) overexpression of llt1 (ocil, clec2d) on prostate cancer cells Cd122 expression is maintained on cd8 + t cells and identifies severely Nk cell lectin receptor ligand human killer type function natural frontiersin immunology frontiers figure fimmu gene
(PDF) Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances
Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer Cd122 cd8 severely maintained identifies exhausted Prostate overexpression inhibits interaction cd161 mediated nk cells
Prostate cancer nk interaction
Cells killer natural defines distinct nk frontiersin subset inflammatory functionally pro figure gating fimmu(pdf) blocking llt1 (clec2d, ocil)-nkrp1a (cd161) interaction enhances Prostate nk cell inhibits killing cells mediated overexpression interaction cancer throughFigure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer.
Cells cd8 memory cytotoxic mait frontiersin therapeutic potential high figure fimmuTriple enhances lysis blocking negative mediated interaction killer cells breast cancer cell natural .
![Frontiers | Modulation of NK Cell Function by Genetically Coupled C](https://i2.wp.com/www.frontiersin.org/files/Articles/66248/fimmu-04-00362-HTML/image_m/fimmu-04-00362-g002.jpg)
![(PDF) Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells](https://i2.wp.com/i1.rgstatic.net/publication/307952143_Overexpression_of_LLT1_OCIL_CLEC2D_on_prostate_cancer_cells_inhibits_NK_cell-mediated_killing_through_LLT1-NKRP1A_CD161_interaction/links/5807c1e908ae5ed04bfe7dbb/largepreview.png)
(PDF) Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells
![Frontiers | CD161 Defines a Functionally Distinct Subset of Pro](https://i2.wp.com/www.frontiersin.org/files/Articles/312468/fimmu-09-00486-HTML/image_m/fimmu-09-00486-g001.jpg)
Frontiers | CD161 Defines a Functionally Distinct Subset of Pro
![Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer](https://i2.wp.com/d3i71xaburhd42.cloudfront.net/44ba4690635133ea1eda23ecbefbb34bef073ea1/5-Figure3-1.png)
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
![Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer](https://i2.wp.com/ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/44ba4690635133ea1eda23ecbefbb34bef073ea1/3-Figure1-1.png)
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
![CD122 expression is maintained on CD8 + T cells and identifies severely](https://i2.wp.com/www.researchgate.net/profile/Jean-Christophe-Beltra/publication/307510784/figure/fig6/AS:667128562737156@1536067252610/CD122-expression-is-maintained-on-CD8-T-cells-and-identifies-severely-exhausted-cells.png)
CD122 expression is maintained on CD8 + T cells and identifies severely
![(PDF) Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances](https://i2.wp.com/i1.rgstatic.net/publication/326234289_Blocking_LLT1_CLEC2D_OCIL-NKRP1A_CD161_interaction_enhances_natural_killer_cell-mediated_lysis_of_triple-negative_breast_cancer_cells/links/5b5b0950a6fdccf0b2fa5d56/largepreview.png)
(PDF) Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances
![Frontiers | CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High](https://i2.wp.com/www.frontiersin.org/files/Articles/613204/fimmu-11-613204-HTML/image_m/fimmu-11-613204-g001.jpg)
Frontiers | CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High